Fluorescent probes for bioimaging of potential biomarkers in Parkinson's disease

L Gao, W Wang, X Wang, F Yang, L Xie… - Chemical Society …, 2021 - pubs.rsc.org
Parkinson's disease (PD), as the second most common neurodegenerative disease, is
caused by complex pathological processes and currently remains very difficult to treat. PD …

[PDF][PDF] -Tropane alkaloids as medicinally useful natural products and their synthetic derivatives as new drugs.

G Grynkiewicz, M Gadzikowska - Pharmacological Reports, 2008 - if-pan.krakow.pl
Secondary metabolites of Solanaceae plants, sharing tropane skeleton as a common
structural feature, are sharply divided into two classes: tropine and ecgonine derivatives …

Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-azido-3-[125I] iodophenyl) butyl]-2β-carbomethoxy-3β-(4-chlorophenyl) …

ML Parnas, JD Gaffaney, MF Zou, JR Lever… - Molecular …, 2008 - ASPET
The novel photoaffinity ligand N-[4-(4-azido-3-125I-iodophenyl)-butyl]-2-β-carbomethoxy-3β-
(4-chlorophenyl) tropane ([125I] MFZ 2-24) was used to investigate the site for cocaine …

Localization of cocaine analog [125I] RTI 82 irreversible binding to transmembrane domain 6 of the dopamine transporter

RA Vaughan, DS Sakrikar, ML Parnas, S Adkins… - Journal of Biological …, 2007 - ASBMB
The site of cocaine binding on the dopamine transporter (DAT) was investigated using the
photoactivatable irreversible cocaine analog [125 I] 3β-(p-chlorophenyl) tropane-2β …

Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter …

DJ Lapinsky, R Velagaleti, N Yarravarapu, Y Liu… - Bioorganic & medicinal …, 2011 - Elsevier
In contrast to tropane-based compounds such as benztropine and cocaine, non-tropane-
based photoaffinity ligands for the dopamine transporter (DAT) are relatively unexplored …

Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters

CK Surratt, OT Ukairo, S Ramanujapuram - The AAPS journal, 2005 - Springer
The plasma membrane monoamine transporters terminate neurotransmission by removing
dopamine, norepinephrine, or serotonin from the synaptic cleft between neurons. Specific …

(±)-2-(N-tert-Butylamino)-3′-[125I]-iodo-4′-azidopropiophenone: A dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on …

DJ Lapinsky, S Aggarwal, TL Nolan, CK Surratt… - Bioorganic & medicinal …, 2012 - Elsevier
Towards addressing the knowledge gap of how bupropion interacts with the dopamine
transporter (DAT) and nicotinic acetylcholine receptors (nAChRs), a ligand was synthesized …

Design and synthesis of a novel photoaffinity ligand for the dopamine and serotonin transporters based on 2β-carbomethoxy-3β-biphenyltropane

AH Newman, JH Cha, J Cao, T Kopajtic… - Journal of medicinal …, 2006 - ACS Publications
Tropane-based photoaffinity ligands covalently bind to discrete points of attachment on the
dopamine transporter (DAT). To further explore structure− activity relations, a ligand in which …

A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone

DJ Lapinsky, S Aggarwal, Y Huang, CK Surratt… - Bioorganic & medicinal …, 2009 - Elsevier
Non-tropane-based photoaffinity ligands for the dopamine transporter (DAT) are relatively
unexplored in contrast to tropane-based compounds such as cocaine. In order to fill this …

Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram

V Kumar, N Yarravarapu, DJ Lapinsky… - Journal of medicinal …, 2015 - ACS Publications
Three photoaffinity ligands (PALs) for the human serotonin transporter (hSERT) were
synthesized based on the selective serotonin reuptake inhibitor (SSRI),(S)-citalopram (1) …